Please provide your email address to receive an email when new articles are posted on . NeuroPace Inc. announced that the first patient with Lennox-Gastaut Syndrome was treated in its investigational ...

CLEARWATER — It’s easier to feel than to see the slight bump on Emma Coto’s head. It comes from a small electrical device, reminiscent of the bottom half of an old flip phone, that doctors implanted ...

A group of medical professionals have pioneered the path to reducing epileptic seizures in North Louisiana. In late July, a medical team from Ochsner LSU Health Shreveport performed their first ...

London-based medical device manufacturer LivaNova has announced FDA approval of its most recent Vagus Nerve Stimulation Therapy (VNS Therapy) System, which will be the smallest and lightest responsive ...

A UNSW biomedical expert explains how neurostimulation can already treat conditions like chronic pain, Parkinson's disease and hearing loss - and why ...

Cantor Fitzgerald initiated coverage on NeuroPace Inc (NASDAQ:NPCE), a commercial-stage medical device company focused on drug-resistant epilepsy treatment through the company's responsive ...

The National Institutes of Health awarded a group of Garden State and fellow researchers a $2.8 million grant to improve implantable devices for patients with epilepsy. RWJBarnabas Health announced ...

HOUSTON, TEXAS, March 14, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that it has commenced sales of its second generation ...

Neurostimulation in the New Decade Disruptive innovation has defined the history of the medical device industry. Novel devices and procedures have replaced established medical practices in various ...